Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban.

Author: AnsellJack E, BakhruSasha H, BrownKaren, CostinJames C, DishyVictor, GrossoMichael A, LanzHans J, LaulichtBryan E, MercuriMichele F, NoveckRobert J, SteinerSolomon S

Paper Details 
Original Abstract of the Article :
Of the new direct oral anticoagulants, direct factor Xa inhibitors are limited by the absence of a proven reversal agent. We assessed the safety, tolerability and impact on anticoagulation reversal of ciraparantag (PER977) alone and following a 60 mg dose of the FXa inhibitor edoxaban. Escalating, s...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260118/

データ提供:米国国立医学図書館(NLM)

A New Dawn for Anticoagulation Reversal: Ciraparantag Takes the Stage

The world of direct oral anticoagulants, particularly factor Xa inhibitors like edoxaban, has been a bit like a desert oasis – promising relief but lacking a reliable way to reverse their effects. Enter ciraparantag, a potential game-changer, making its grand entrance in this research. It’s like a camel caravan bringing life-saving water to a thirsty land. Researchers, using a double-blind, placebo-controlled study, explored the safety and efficacy of ciraparantag alone and in combination with edoxaban. Their findings? A single IV dose of ciraparantag (100 to 300 mg) successfully reversed anticoagulation within a mere 10 minutes, with the effects lasting for a full 24 hours. It’s like a quick sip of fresh, clear water instantly revitalizing a weary traveler. The researchers observed some minor, non-dose-limiting side effects like flushing, but overall, ciraparantag proved to be safe and well-tolerated.

Ciraparantag: A Powerful Tool for Anticoagulation Reversal

This study unveils the immense potential of ciraparantag as a potent reversal agent for edoxaban-induced anticoagulation. The rapid onset and sustained duration of action make it a valuable tool for managing bleeding complications associated with these medications. This discovery is like finding a hidden spring in the middle of the desert, providing a vital source of water for those in need.

A New Era of Anticoagulation Management

The ability to quickly and reliably reverse anticoagulation with ciraparantag opens a new era of safety and control for patients on direct oral anticoagulants. It’s like having a trustworthy guide leading you through the desert, ensuring your safety and well-being. We can now confidently navigate the complexities of anticoagulation management, knowing that a powerful antidote is available to mitigate potential risks.

Dr.Camel's Conclusion

Ciraparantag, like a refreshing breeze in the desert, offers a new wave of hope for patients on direct oral anticoagulants. The ability to safely and effectively reverse the effects of these medications significantly enhances patient safety and provides peace of mind. This is a significant advancement in the field of anticoagulation management, paving the way for a safer and more controlled therapeutic experience.

Date :
  1. Date Completed 2018-02-26
  2. Date Revised 2022-07-01
Further Info :

Pubmed ID

27853809

DOI: Digital Object Identifier

PMC6260118

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.